A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation

FLT3-ITD-mutated acute myeloid leukemia (AML) remains a therapeutic challenge. FLT3 inhibition in the setting of minimal residual disease and a new immune system via allogeneic transplantation offers a promise of improved survival for these patients. We performed a prospective study of patients with...

全面介紹

Na minha lista:
書目詳細資料
發表在:Biol Blood Marrow Transplant
Main Authors: Pratz, Keith W., Rudek, Michelle A., Smith, B. Douglas, Karp, Judith, Gojo, Ivana, Dezern, Amy, Jones, Richard J., Greer, Jackie, Gocke, Christopher, Baer, Maria R., Duong, Vu H., Rosner, Gary, Zahurak, Marianna, Wright, John J., Emadi, Ashkan, Levis, Mark
格式: Artigo
語言:Inglês
出版: 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7001148/
https://ncbi.nlm.nih.gov/pubmed/31550496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.09.023
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍